Recent research from Weill Cornell Medicine has unveiled a promising preclinical discovery that could significantly enhance the effectiveness of cancer immunotherapy for B-cell non-Hodgkin lymphomas (B-NHL). The study focuses on the use of EZ## inhibitors, an emerging class of anticancer drugs, in
Drug addiction has been a persistent issue throughout human history, documented from ancient times. Traditionally viewed as a moral failing rather than a treatable disease, the perception of addiction began to shift in the 20th century with scientific discoveries highlighting its basis in brain
In recent years, health research has been undergoing two major, yet seemingly opposing, shifts: a deep dive into individual-centric medicine and a broadened focus on population-wide studies. On the individual level, advancements in genomics are driving the shift toward personalized medicine, where
In a remarkable breakthrough in breast cancer treatment, a novel cell-based immunotherapy developed by Dr. Gary Koski from Kent State University and Dr. Brian J. Czerniecki from the Moffitt Cancer Center has been recently accepted for publication in JAMA Oncology. This innovative approach harnesses
A groundbreaking gene therapy showing promise in preventing premature births and treating placental growth insufficiency holds the potential to significantly improve pregnancies worldwide. This revolutionary therapy is being developed by a dedicated team led by Dr. Helen N. Jones from the
Scientists have long sought to understand the various factors that contribute to the prevalence of cancer, and recent research has shed light on a surprising potential culprit: Escherichia coli (E. coli). A study conducted by researchers from the Wellcome Sanger Institute and the University of
